by McDermott + Bull | Feb 1, 2023 | Article, Healthcare + Life Sciences, Healthcare + Life Sciences Article, Ken Dropiewski, Ken Dropiewski Article
MEDTECH + LIFE SCIENCES OUTLOOK IN 2023 2022 was an interesting year, to say the least. It was the tale of two markets. After the extremely volatile years of 2020 and 2021, no one could have predicted the sheer amount of momentum that lay ahead in 2022. The economy...
by McDermott + Bull | Jan 11, 2023 | Investor Insights, Ken Dropiewski, Video
McDermott + Bull Partner Ken Dropiewski interviews Gilde Healthcare General Partner Geoff Pardo in his series, Investor Insights in Life Sciences + MedTech. In the conversations below, Ken and Geoff discuss what venture in MedTech will look like in 2023, what Gilde...
by McDermott + Bull | Nov 28, 2022 | Company News, Ken Dropiewski, Press Releases
IRVINE, CA (August 30, 2022) – McDermott + Bull announces the addition of Shelby Varon as Director of Business Development for the firm’s national MedTech and Life Sciences Group where she will work closely with McDermott + Bull Partner Ken Dropiewski in...
by McDermott + Bull | Nov 28, 2022 | Healthcare + Life Sciences, Healthcare + Life Sciences Placement Announcement, Ken Dropiewski, Ken Dropiewski Placement Announcement, Michael Matranga, Placement Announcement, Technology Placement Announcement
McDermott + Bull has successfully placed Garrett Kiesle as President + Chief Operating Officer at Shalby Advanced Technologies Inc. (SAT). Garrett will help drive the organization’s commercial execution and expansion nationally and internationally. He will be the face...
by McDermott + Bull | Nov 24, 2022 | Article, Healthcare + Life Sciences, Healthcare + Life Sciences Article, Ken Dropiewski, Ken Dropiewski Article
Heading into 2022, many expected the rapid continuation of strong initial public offerings (IPOs) and merger + acquisition (M+A) activity. Wow, that was off. The underestimated implications of supply chain issues, geopolitical concerns, and Federal Trade Commission...
by McDermott + Bull | Nov 16, 2022 | Investor Insights, Ken Dropiewski, Video
McDermott + Bull Partner Ken Dropiewski interviews Endeavour Venture Partner Rob Barmann in his series, Investor Insights in Life Sciences + MedTech. In the conversations below, Ken and Rob discuss a range of topics from typical investment sizes to non-traditional...
